141 related articles for article (PubMed ID: 38723212)
1. Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
Tentori CA; Gregorio C; Robin M; Gagelmann N; Gurnari C; Ball S; Caballero Berrocal JC; Lanino L; D'Amico S; Spreafico M; Maggioni G; Travaglino E; Sauta E; Meggendorfer M; Zhao LP; Campagna A; ; Savevski V; Santoro A; Al Ali N; Sallman D; Sole F; Garcia-Manero G; Germing U; Kroger N; Kordasti S; Santini V; Sanz G; Kern W; Platzbecker U; Diez-Campelo M; Maciejewski JP; Ades L; Fenaux P; Haferlach T; Zeidan AM; Castellani G; Komrokji R; Ieva F; Della Porta MG
J Clin Oncol; 2024 May; ():JCO2302175. PubMed ID: 38723212
[TBL] [Abstract][Full Text] [Related]
2. Improving Revised International Prognostic Scoring System Pre-Allogeneic Stem Cell Transplantation Does Not Translate Into Better Post-Transplantation Outcomes for Patients with Myelodysplastic Syndromes: A Single-Center Experience.
Alzahrani M; Power M; Abou Mourad Y; Barnett M; Broady R; Forrest D; Gerrie A; Hogge D; Nantel S; Sanford D; Song K; Sutherland H; Toze C; Nevill T; Narayanan S
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1209-1215. PubMed ID: 29474870
[TBL] [Abstract][Full Text] [Related]
3. Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.
Della Porta MG; Jackson CH; Alessandrino EP; Rossi M; Bacigalupo A; van Lint MT; Bernardi M; Allione B; Bosi A; Guidi S; Santini V; Malcovati L; Ubezio M; Milanesi C; Todisco E; Voso MT; Musto P; Onida F; Iori AP; Cerretti R; Grillo G; Molteni A; Pioltelli P; Borin L; Angelucci E; Oldani E; Sica S; Pascutto C; Ferretti V; Santoro A; Bonifazi F; Cazzola M; Rambaldi A
Leukemia; 2017 Nov; 31(11):2449-2457. PubMed ID: 28321120
[TBL] [Abstract][Full Text] [Related]
4. Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.
Koreth J; Pidala J; Perez WS; Deeg HJ; Garcia-Manero G; Malcovati L; Cazzola M; Park S; Itzykson R; Ades L; Fenaux P; Jadersten M; Hellstrom-Lindberg E; Gale RP; Beach CL; Lee SJ; Horowitz MM; Greenberg PL; Tallman MS; DiPersio JF; Bunjes D; Weisdorf DJ; Cutler C
J Clin Oncol; 2013 Jul; 31(21):2662-70. PubMed ID: 23797000
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Alessandrino EP; Porta MG; Malcovati L; Jackson CH; Pascutto C; Bacigalupo A; Teresa van Lint M; Falda M; Bernardi M; Onida F; Guidi S; Iori AP; Cerretti R; Marenco P; Pioltelli P; Angelucci E; Oneto R; Ripamonti F; Rambaldi A; Bosi A; Cazzola M;
Am J Hematol; 2013 Jul; 88(7):581-8. PubMed ID: 23606215
[TBL] [Abstract][Full Text] [Related]
6. Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study.
Condorelli A; Frigeni M; Quaresmini G; Salmoiraghi S; Pavoni C; Grassi A; Raviglione M; Civini A; Putelli A; Lussana F; Finazzi MC; Algarotti A; Micò MC; Spinelli O; Rambaldi A
Leuk Res; 2024 Jul; 142():107529. PubMed ID: 38820666
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
de Witte T; Bowen D; Robin M; Malcovati L; Niederwieser D; Yakoub-Agha I; Mufti GJ; Fenaux P; Sanz G; Martino R; Alessandrino EP; Onida F; Symeonidis A; Passweg J; Kobbe G; Ganser A; Platzbecker U; Finke J; van Gelder M; van de Loosdrecht AA; Ljungman P; Stauder R; Volin L; Deeg HJ; Cutler C; Saber W; Champlin R; Giralt S; Anasetti C; Kröger N
Blood; 2017 Mar; 129(13):1753-1762. PubMed ID: 28096091
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic significance of pretransplantation evaluation of IPSS-R and WPSS in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation].
Lu CQ; Hou C; Wang P; Zhang LW; Fan Y; Wu DP; Xu Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):247-254. PubMed ID: 35405784
[No Abstract] [Full Text] [Related]
9. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
Sauta E; Robin M; Bersanelli M; Travaglino E; Meggendorfer M; Zhao LP; Caballero Berrocal JC; Sala C; Maggioni G; Bernardi M; Di Grazia C; Vago L; Rivoli G; Borin L; D'Amico S; Tentori CA; Ubezio M; Campagna A; Russo A; Mannina D; Lanino L; Chiusolo P; Giaccone L; Voso MT; Riva M; Oliva EN; Zampini M; Riva E; Nibourel O; Bicchieri M; Bolli N; Rambaldi A; Passamonti F; Savevski V; Santoro A; Germing U; Kordasti S; Santini V; Diez-Campelo M; Sanz G; Sole F; Kern W; Platzbecker U; Ades L; Fenaux P; Haferlach T; Castellani G; Della Porta MG
J Clin Oncol; 2023 May; 41(15):2827-2842. PubMed ID: 36930857
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.
Gauthier J; Damaj G; Langlois C; Robin M; Michallet M; Chevallier P; Beguin Y; N'guyen S; Bories P; Blaise D; Cornillon J; Clavert A; Mohty M; Huynh A; Thiébaut-Bertrand A; Vigouroux S; Duhamel A; Yakoub-Agha I
Transplantation; 2015 Aug; 99(8):1672-80. PubMed ID: 25769079
[TBL] [Abstract][Full Text] [Related]
11. Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.
Lee WH; Tsai MT; Tsai CH; Tien FM; Lo MY; Tseng MH; Kuo YY; Liu MC; Yang YT; Chen JC; Tang JL; Sun HI; Chuang YK; Lin LI; Chou WC; Lin CC; Hou HA; Tien HF
Blood Cancer J; 2023 Aug; 13(1):120. PubMed ID: 37558665
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Della Porta MG; Alessandrino EP; Bacigalupo A; van Lint MT; Malcovati L; Pascutto C; Falda M; Bernardi M; Onida F; Guidi S; Iori AP; Cerretti R; Marenco P; Pioltelli P; Angelucci E; Oneto R; Ripamonti F; Bernasconi P; Bosi A; Cazzola M; Rambaldi A;
Blood; 2014 Apr; 123(15):2333-42. PubMed ID: 24558201
[TBL] [Abstract][Full Text] [Related]
13. Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes.
Abel GA; Koreth J
Curr Opin Hematol; 2013 Mar; 20(2):150-6. PubMed ID: 23298879
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of new IPSS-Molecular model and comparison of different prognostic systems in patients with myelodysplastic syndrome.
Ma J; Gu Y; Wei Y; Wang X; Wang P; Song C; Ge Z
Blood Sci; 2023 Jul; 5(3):187-195. PubMed ID: 37546714
[TBL] [Abstract][Full Text] [Related]
15. Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.
Mishra A; Corrales-Yepez M; Ali NA; Kharfan-Dabaja M; Padron E; Zhang L; Epling-Burnette PK; Pinilla-Ibarz J; Lancet JE; List AF; Komrokji RS
Am J Hematol; 2013 Jul; 88(7):566-70. PubMed ID: 23605934
[TBL] [Abstract][Full Text] [Related]
16. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
Bernard E; Tuechler H; Greenberg PL; Hasserjian RP; Arango Ossa JE; Nannya Y; Devlin SM; Creignou M; Pinel P; Monnier L; Gundem G; Medina-Martinez JS; Domenico D; Jädersten M; Germing U; Sanz G; van de Loosdrecht AA; Kosmider O; Follo MY; Thol F; Zamora L; Pinheiro RF; Pellagatti A; Elias HK; Haase D; Ganster C; Ades L; Tobiasson M; Palomo L; Della Porta MG; Takaori-Kondo A; Ishikawa T; Chiba S; Kasahara S; Miyazaki Y; Viale A; Huberman K; Fenaux P; Belickova M; Savona MR; Klimek VM; Santos FPS; Boultwood J; Kotsianidis I; Santini V; Solé F; Platzbecker U; Heuser M; Valent P; Ohyashiki K; Finelli C; Voso MT; Shih LY; Fontenay M; Jansen JH; Cervera J; Gattermann N; Ebert BL; Bejar R; Malcovati L; Cazzola M; Ogawa S; Hellström-Lindberg E; Papaemmanuil E
NEJM Evid; 2022 Jul; 1(7):EVIDoa2200008. PubMed ID: 38319256
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms.
Polprasert C; Niparuck P; Rattanathammethee T; Kobbuaklee S; Lanamtieng T; Rojnuckarin P
Hematology; 2022 Dec; 27(1):1301-1304. PubMed ID: 36519260
[TBL] [Abstract][Full Text] [Related]
18. Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
Della Porta MG; Gallì A; Bacigalupo A; Zibellini S; Bernardi M; Rizzo E; Allione B; van Lint MT; Pioltelli P; Marenco P; Bosi A; Voso MT; Sica S; Cuzzola M; Angelucci E; Rossi M; Ubezio M; Malovini A; Limongelli I; Ferretti VV; Spinelli O; Tresoldi C; Pozzi S; Luchetti S; Pezzetti L; Catricalà S; Milanesi C; Riva A; Bruno B; Ciceri F; Bonifazi F; Bellazzi R; Papaemmanuil E; Santoro A; Alessandrino EP; Rambaldi A; Cazzola M
J Clin Oncol; 2016 Oct; 34(30):3627-3637. PubMed ID: 27601546
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.
van Spronsen MF; Ossenkoppele GJ; Westers TM; van de Loosdrecht AA
Eur J Cancer; 2016 Mar; 56():10-20. PubMed ID: 26798967
[TBL] [Abstract][Full Text] [Related]
20. A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.
GenoMed4All consortium
Lancet Haematol; 2023 Feb; 10(2):e117-e128. PubMed ID: 36436542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
